Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
21 July, 2018 21:02 IST
Glenmark to introduce generic Seretide Accuhaler in Denmark
Source: IRIS | 16 May, 2018, 11.59AM
Comments  |  Post Comment

Glenmark Pharmaceuticals Europe (Glenmark) today announced that it has launched a generic version of Seretide Accuhaler in Denmark. This is Glenmark's first inhaled respiratory product launch in Europe.
 
Glenmark is the first generic company to receive regulatory approval for substitution in Denmark for its generic of Seretide Accuhaler Glenmark had entered into a strategic development & licensing agreement with Celon Pharma S.A. (Celon) to develop and market a generic version of GlaxoSmithKline's Seretide Accuhaler product-Fluticasone/Salmeterol dry powder inhaler in 15 European countries. Fluticasone/Salmeterol dry powder inhaler is a combination product for the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Glenmark has already received National Marketing Authorizations for the product in Sweden, Finland, Norway and Iceland.

''Denmark is the first country in Europe where Glenmark has launched its generic Fluticasone/Salmeterol Dry powder Inhaler (DPI) and we plan to commercialize this product across the Nordics in the near future. The grant of substitution in Denmark for this complex product affirms Glenmark's capabilities in the respiratory segment,'' said Achin Gupta, Executive Vice President & Business Head of Europe and Latin America, Glenmark Pharmaceuticals.

(Q,N,C,F)*

Shares of the company gained Rs 8.25, or 1.63%, to trade at Rs 514.50. The total volume of shares traded was 11,625 at the BSE (11.46 a.m., Wednesday).



Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
Wipro Q1 earnings rise 16.3% q-o-q to Rs 20.93 bn - 20-Jul-2018 16:53
Sensex ends 145 points higher; Nifty settles at 11,010-level - 20-Jul-2018 16:08
PNC Infratech receives LOI for Purvanchal Expressway EPC Projects - 20-Jul-2018 15:52
Himachal Futuristic Communications receives orders worth Rs 20.04 bn - 20-Jul-2018 15:45
Zydus Cadila gets final nod for Spironolactone tablets - 20-Jul-2018 15:40
Bank of Baroda signs MoU with 10 companies - 20-Jul-2018 15:34
NCLT approves JK Paper's Rs 3.71 bn bid for Sirpur Paper Mills - 20-Jul-2018 13:40
Global oil brand ECSTAR now at Maruti Suzuki ARENA network - 20-Jul-2018 10:23
Sensex gains over 100 points; Nifty trades at 10,984 - 20-Jul-2018 10:05
Gayatri Projects wins two road contracts worth Rs 27.59 bn - 20-Jul-2018 09:58
Jain Irrigation Systems bags project worth Rs 9.75 bn - 20-Jul-2018 09:53
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer